1 hour ago
3
Soumya Eswaran
Wed, June 17, 2026 astatine 9:16 AM CDT 3 min read
Renaissance Investment Management, an concern absorption company, released its Q1 2026 "Large Cap Growth Strategy." A transcript of the missive tin beryllium downloaded here. Stocks fell sharply successful the archetypal 4th owed to the Iran conflict. The Energy and Materials sectors outperformed, Financials and Consumer Discretionary lagged. Large-cap stocks underperformed smaller-cap stocks, and Value outperformed Growth. The portfolio outperformed the S&P 500's -4.3% instrumentality but lagged the Russell 1000 Growth Index, which fell 9.8%. In this uncertain environment, the steadfast remains alert of the risks and emerging concern opportunities. In addition, you tin cheque the Strategy's apical 5 holdings for its champion picks for 2026.
In its first-quarter 2026 capitalist letter, Renaissance Investment Large Cap Growth Strategy highlighted Zoetis Inc. (NYSE:ZTS) arsenic anewly added position. Zoetis Inc. (NYSE:ZTS) is an carnal wellness institution focused connected carnal wellness medications, vaccines, and diagnostic products. On June 16, 2026, Zoetis Inc. (NYSE:ZTS) closed astatine $79.33 per share. One-month instrumentality of Zoetis Inc. (NYSE:ZTS) was 0.04%, and its shares mislaid 48.57% implicit the past 52 weeks. Zoetis Inc. (NYSE:ZTS) has a marketplace capitalization of $33.25 billion.
Renaissance Investment Large Cap Growth Strategy stated the pursuing regarding Zoetis Inc. (NYSE:ZTS) successful its Q1 2026 capitalist letter:
"In the archetypal quarter, we made respective changes to our portfolio arsenic marketplace rotation provided america with respective opportunities to upgrade the prime of the portfolio. In March, we added a caller presumption successful the Health Care assemblage with Zoetis Inc. (NYSE:ZTS), the planetary person successful vaccines and pharmaceuticals for some the companion carnal and livestock markets. Zoetis has faced hard maturation comparisons since the second portion of 2022, aft an archetypal spike successful request caused by COVID-driven favored adoptions wore disconnected and operational missteps successful caller cause launches hampered growth. However, we judge that gross is positioned to reaccelerate arsenic COVID-era pets attack the property erstwhile preventive and protective treatments begin, driving request for nonrecreational veterinary services. We peculiarly similar the company's caller cause pipeline, with caller cause launches implicit the adjacent 4 years targeting cancer, kidney, heart, obesity, and anxiousness treatments. In addition, we judge that expanding request for macromolecule depletion and a relaunch of the company's symptom medicine volition likewise assistance reverse caller gross deceleration."
Zoetis Inc. (NYSE:ZTS) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 57 hedge money portfolios held Zoetis Inc. (NYSE:ZTS) astatine the extremity of the archetypal quarter, compared to 69 successful the erstwhile quarter. While we admit the imaginable of Zoetis Inc. (NYSE:ZTS) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
English (CA) · 
English (US) · 
Spanish (MX) ·